UBE2T and neoplasm: We found that increased tumor growth in vivo triggered by FLAG-UBE2T could be reversed by simultaneous transfection of HA-NEDD4L (Fig. 5A), due to overexpression of NEDD4L caused UBE2T reduction (Fig. 5B).